{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:21:38Z","timestamp":1781191298366,"version":"3.54.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jgo.2022.06.010","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:55:38Z","timestamp":1657068938000},"page":"1092-1102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Associations between outcome variables of nutritional screening methods and systemic treatment tolerance in patients with colorectal cancer: A systematic review"],"prefix":"10.1016","volume":"13","author":[{"given":"Kris","family":"Beukers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.J.","family":"Voorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ria","family":"Trepels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yes","family":"van de Wouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Vogelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco C.","family":"Havermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryska L.G.","family":"Janssen-Heijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jgo.2022.06.010_bb0005","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"13","key":"10.1016\/j.jgo.2022.06.010_bb0010","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMoa1713709","article-title":"Duration of adjuvant chemotherapy for stage III Colon Cancer","volume":"378","author":"Grothey","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jgo.2022.06.010_bb0015","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S1470-2045(14)70330-4","article-title":"FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial","volume":"15","author":"Heinemann","year":"2014","journal-title":"Lancet Oncol"},{"issue":"25","key":"10.1016\/j.jgo.2022.06.010_bb0020","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1200\/JCO.2010.34.3426","article-title":"Adjuvant chemotherapy for stage II colon cancer with poor prognostic features","volume":"29","author":"O\u2019Connor","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2022.06.010_bb0025","author":"Cijfers over kanker [Internet]"},{"issue":"14","key":"10.1016\/j.jgo.2022.06.010_bb0030","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.3748\/wjg.v20.i14.3751","article-title":"Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation","volume":"20","author":"Lee","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"23","key":"10.1016\/j.jgo.2022.06.010_bb0035","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1002\/cncr.33122","article-title":"Association of malnutrition with geriatric assessment impairments and health-related quality of life among older adults with gastrointestinal malignancies","volume":"126","author":"Williams","year":"2020","journal-title":"Cancer."},{"issue":"2","key":"10.1016\/j.jgo.2022.06.010_bb0040","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12603-017-0882-7","article-title":"Occurrence of malnutrition and associated factors in community-dwelling older adults: those with a recent diagnosis of cancer are at higher risk","volume":"22","author":"Van Den Broeke","year":"2018","journal-title":"J Nutr Health Aging"},{"issue":"1","key":"10.1016\/j.jgo.2022.06.010_bb0045","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.clnu.2010.07.015","article-title":"Associations between nutritional status, weight loss, radiotherapy treatment toxicity and treatment outcomes in gastrointestinal cancer patients","volume":"30","author":"Hill","year":"2011","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jgo.2022.06.010_bb0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12937-015-0081-5","article-title":"Preoperative malnutrition assessments as predictors of postoperative mortality and morbidity in colorectal cancer: an analysis of ACS-NSQIP","volume":"14","author":"Hu","year":"2015","journal-title":"Nutr J"},{"issue":"14","key":"10.1016\/j.jgo.2022.06.010_bb0055","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1200\/JCO.2007.10.6559","article-title":"Comprehensive geriatric assessment for older patients with cancer","volume":"25","author":"Extermann","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jgo.2022.06.010_bb0060","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jgo.2013.04.001","article-title":"Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy","volume":"4","author":"Aaldriks","year":"2013","journal-title":"J Geriatr Oncol"},{"issue":"6","key":"10.1016\/j.jgo.2022.06.010_bb0065","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.clnu.2016.12.003","article-title":"Association between cachexia, chemotherapy and outcomes in older cancer patients: a systematic review","volume":"36","author":"Caillet","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jgo.2022.06.010_bb0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jclinepi.2016.02.020","article-title":"Content validity across methods of malnutrition assessment in patients with cancer is limited","volume":"76","author":"Sealy","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.jgo.2022.06.010_bb0075","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1186\/s12885-020-07052-4","article-title":"Nutritional status according to the mini nutritional assessment (MNA)\u00ae as potential prognostic factor for health and treatment outcomes in patients with cancer - a systematic review","volume":"20","author":"Torbahn","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.jgo.2022.06.010_bb0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jgo.2018.04.001","article-title":"Patient- and tumor-related predictors of chemotherapy intolerance in older patients with cancer: a systematic review","volume":"10","author":"van Abbema","year":"2019","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2022.06.010_bb0085","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgo.2022.06.010_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"issue":"4","key":"10.1016\/j.jgo.2022.06.010_bb0095","first-page":"420","article-title":"The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: a systematic review","volume":"106","author":"Eriksen","year":"2018","journal-title":"J Med Libr Associat JMLA"},{"issue":"1","key":"10.1016\/j.jgo.2022.06.010_bb0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0021-9681(60)90137-5","article-title":"Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide","volume":"11","author":"Zubrod","year":"1960","journal-title":"J Chronic Dis"},{"issue":"9","key":"10.1016\/j.jgo.2022.06.010_bb0105","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"10.1016\/j.jgo.2022.06.010_bb0110","first-page":"e59","article-title":"Factors predicting adherence to a tailored-dose adjuvant treatment on the basis of geriatric assessment in elderly people with colorectal Cancer: a prospective study","volume":"17","author":"Antonio","year":"2018","journal-title":"Clin Colorectal Cancer"},{"issue":"4","key":"10.1016\/j.jgo.2022.06.010_bb0115","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01635581.2014.894103","article-title":"Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer","volume":"66","author":"Barret","year":"2014","journal-title":"Nutr Cancer"},{"issue":"5\u20136","key":"10.1016\/j.jgo.2022.06.010_bb0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000335478","article-title":"Nutritional status affects treatment tolerability and survival in metastatic colorectal cancer patients: results of an AGEO prospective multicenter study","volume":"81","author":"Barret","year":"2011","journal-title":"Oncology."},{"issue":"12","key":"10.1016\/j.jgo.2022.06.010_bb0125","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1245\/s10434-016-5360-7","article-title":"Sarcopenia is associated with chemotherapy toxicity in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer","volume":"23","author":"Chemama","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.jgo.2022.06.010_bb0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jgo.2017.10.002","article-title":"Integrating geriatric assessment in the first line chemotherapy treatment in older patients with metastatic colorectal cancer: results of a prospective observational cohort study (AVAPLUS)","volume":"9","author":"Decoster","year":"2018","journal-title":"J Geriatric Oncol"},{"issue":"3","key":"10.1016\/j.jgo.2022.06.010_bb0135","article-title":"Relevance of geriatric assessment in older patients with colorectal cancer","volume":"16","author":"Decoster","year":"2017","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.jgo.2022.06.010_bb0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejca.2019.07.011","article-title":"Evaluation of two nutritional scores\u2019 association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study","volume":"119","author":"Gallois","year":"2019","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.jgo.2022.06.010_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2020.101603","article-title":"Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: an AGEO prospective multicenter study","volume":"45","author":"Gallois","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"6","key":"10.1016\/j.jgo.2022.06.010_bb0150","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1177\/1078155220959427","article-title":"Does nutritional status affect treatment tolarability, response and survival in metastatic colorectal cancer patients? Results of a prospective multicenter study","volume":"27","author":"Karabulut","year":"2020","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"10.1016\/j.jgo.2022.06.010_bb0155","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12957-017-1226-0","article-title":"Impact of nutritional status in the era of FOLFOX\/FIRI-based chemotherapy","volume":"15","author":"Okada","year":"2017","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2022.06.010_bb0160","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1634\/theoncologist.2019-0241","article-title":"Predicting chemotherapy toxicity and death in older adults with Colon Cancer: results of MOST study","volume":"25","author":"Retornaz","year":"2020","journal-title":"Oncologist."},{"issue":"12","key":"10.1016\/j.jgo.2022.06.010_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167967","article-title":"The C-reactive protein to albumin ratio as a predictor of severe side effects of adjuvant chemotherapy in stage III colorectal cancer patients","volume":"11","author":"Tominaga","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jgo.2022.06.010_bb0170","article-title":"Role of predictive value of the modified Glasgow prognostic score for later-line chemotherapy in patients with metastatic colorectal cancer","volume":"17","author":"Tsuchihashi","year":"2018","journal-title":"Clin Colorectal Cancer"},{"issue":"6","key":"10.1016\/j.jgo.2022.06.010_bb0175","doi-asserted-by":"crossref","first-page":"885","DOI":"10.21873\/invivo.11009","article-title":"Prognostic impact of a nutritional index including muscle volume in stage 4 colorectal cancer","volume":"30","author":"Nagata","year":"2016","journal-title":"In Vivo"},{"issue":"11","key":"10.1016\/j.jgo.2022.06.010_bb0180","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s12094-019-02080-4","article-title":"Relation between sarcopenia and dose-limiting toxicity in patients with metastatic colorectal cancer who received regorafenib","volume":"21","author":"G\u00f6kyer","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.jgo.2022.06.010_bb0185","author":"Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 [Internet]"},{"issue":"4","key":"10.1016\/j.jgo.2022.06.010_bb0190","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0959-8049(97)10090-9","article-title":"Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?","volume":"34","author":"Andreyev","year":"1998","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.jgo.2022.06.010_bb0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/ijo.2010.111","article-title":"Fat-free mass index: changes and race\/ethnic differences in adulthood","volume":"35","author":"Hull","year":"2011","journal-title":"Int J Obes"},{"issue":"4","key":"10.1016\/j.jgo.2022.06.010_bb0200","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-277X.2010.01070.x","article-title":"Nutritional status of preoperative colorectal cancer patients","volume":"23","author":"Burden","year":"2010","journal-title":"J Hum Nutr Diet"},{"issue":"11","key":"10.1016\/j.jgo.2022.06.010_bb0205","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1158\/1078-0432.CCR-06-3067","article-title":"Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity","volume":"13","author":"Prado","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.jgo.2022.06.010_bb0210","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4240\/wjgs.v7.i12.370","article-title":"Hypoalbuminemia in colorectal cancer prognosis: nutritional marker or inflammatory surrogate?","volume":"7","author":"Nazha","year":"2015","journal-title":"World J Gastrointest Surg"},{"issue":"7","key":"10.1016\/j.jgo.2022.06.010_bb0215","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00004836-200608000-00006","article-title":"Preoperative carcinoembryonic antigen and albumin in predicting survival in patients with colon and rectal carcinomas","volume":"40","author":"Boonpipattanapong","year":"2006","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.jgo.2022.06.010_bb0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0899-9007(01)00729-8","article-title":"The albumin-nutrition connection: separating myth from fact","volume":"18","author":"Fuhrman","year":"2002","journal-title":"Nutrition."},{"issue":"1","key":"10.1016\/j.jgo.2022.06.010_bb0225","first-page":"188","article-title":"Association between an inflammatory-nutritional index and nutritional status in cancer patients","volume":"28","author":"Alberici Pastore","year":"2013","journal-title":"Nutr Hosp"},{"issue":"1","key":"10.1016\/j.jgo.2022.06.010_bb0230","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","article-title":"The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer","volume":"88","author":"Guthrie","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.jgo.2022.06.010_bb0235","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1245\/s10434-014-4048-0","article-title":"The C-reactive protein\/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma","volume":"22","author":"Kinoshita","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2022.06.010_bb0240","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","article-title":"The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer","volume":"39","author":"McMillan","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.jgo.2022.06.010_bb0245","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2008.02.011","article-title":"Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma","volume":"87","author":"Salas","year":"2008","journal-title":"Radiother Oncol"},{"issue":"26","key":"10.1016\/j.jgo.2022.06.010_bb0250","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.3748\/wjg.v16.i26.3310","article-title":"Comparison of different nutritional assessments in detecting malnutrition among gastric cancer patients","volume":"16","author":"Ryu","year":"2010","journal-title":"World J Gastroenterol: WJG"},{"issue":"13","key":"10.1016\/j.jgo.2022.06.010_bb0255","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.26646","article-title":"Predicting the risk of chemotherapy toxicity in older patients: the chemotherapy risk assessment scale for high-age patients (CRASH) score","volume":"118","author":"Extermann","year":"2012","journal-title":"Cancer."},{"issue":"1","key":"10.1016\/j.jgo.2022.06.010_bb0260","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clnu.2018.05.024","article-title":"ESPEN guideline on clinical nutrition and hydration in geriatrics","volume":"38","author":"Volkert","year":"2019","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jgo.2022.06.010_bb0265","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clnesp.2018.07.005","article-title":"Agreement between PG-SGA category and fat-free mass in colorectal cancer patients","volume":"27","author":"R\u00e6der","year":"2018","journal-title":"Clin Nutr ESPEN"},{"issue":"6","key":"10.1016\/j.jgo.2022.06.010_bb0270","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/bjc.2012.350","article-title":"Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery","volume":"107","author":"Lieffers","year":"2012","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.jgo.2022.06.010_bb0275","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jcsm.12436","article-title":"Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients","volume":"10","author":"Kurk","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jgo.2022.06.010_bb0280","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx388.006","article-title":"Impact of sarcopenia on dose limiting toxicities in metastatic colorectal cancer patients (mCRC pts) receiving palliative systemic treatment","volume":"28","author":"Kurk","year":"2017","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.jgo.2022.06.010_bb0285","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jgo.2022.06.010_bb0290","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jclinepi.2022.04.026","article-title":"The performance of three nutritional tools varied in colorectal cancer patients: a retrospective analysis","volume":"149","author":"Ruan","year":"2022","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.jgo.2022.06.010_bb0295","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/jjco\/hyab215","article-title":"Effect of GLIM-defined malnutrition on postoperative clinical outcomes in patients with colorectal cancer","volume":"52","author":"Song","year":"2022","journal-title":"Jpn J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jgo.2022.06.010_bb0300","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jgo.2021.05.004","article-title":"Associations between the Geriatric-8 and 4-meter gait speed test and subsequent delivery of adjuvant chemotherapy in older patients with colon cancer","volume":"12","author":"Beukers","year":"2021","journal-title":"J Geriatr Oncol"},{"issue":"23","key":"10.1016\/j.jgo.2022.06.010_bb0305","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1002\/cncr.25332","article-title":"Risk of mortality in patients with cancer who experience febrile neutropenia","volume":"116","author":"Lyman","year":"2010","journal-title":"Cancer."},{"issue":"14","key":"10.1016\/j.jgo.2022.06.010_bb0310","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.3748\/wjg.v20.i14.3751","article-title":"Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation","volume":"20","author":"Lee","year":"2014","journal-title":"World J Gastroenterol: WJG"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406822001473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406822001473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:58:55Z","timestamp":1761818335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406822001473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":62,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1879406822001473"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2022.06.010","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between outcome variables of nutritional screening methods and systemic treatment tolerance in patients with colorectal cancer: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2022.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}